Literature DB >> 12618710

Ergotism associated with HIV antiviral protease inhibitor therapy.

Zachary K Baldwin1, Chris C Ceraldi.   

Abstract

Ergotism is a rare condition of acute vasospasm found classically in young and middle-aged women taking ergot alkaloid agents to treat migraine headache. We report the case of a young man with human immunodeficiency virus (HIV) positivity and describe the drug interaction between protease inhibitors and ergot alkaloid agents, which most likely predisposed to development of ergot toxicity. The HIV-positive population receiving antiviral therapy may be an under-recognized group at risk for ergotism through decreased hepatic metabolism of ergot preparations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618710     DOI: 10.1067/mva.2003.80

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

1.  Ergotamine-induced upper extremity ischemia: a case report.

Authors:  Man Deuk Kim; Gun Lee; Sung Wook Shin
Journal:  Korean J Radiol       Date:  2005 Apr-Jun       Impact factor: 3.500

Review 2.  A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products.

Authors:  Andrew Stolbach; Karolina Paziana; Harry Heverling; Paul Pham
Journal:  J Med Toxicol       Date:  2015-09

3.  Upper limb artery segmental occlusions due to chronic use of ergotamine combined with itraconazole, treated by thrombolysis.

Authors:  Edoardo Cervi; Stefano Bonardelli; Giuseppe Battaglia; Federico Gheza; Roberto Maffeis; Franco Nodari; Roberto Maroldi; Stefano M Giulini
Journal:  Thromb J       Date:  2011-08-30

4.  Ergotism: Case Report and Review of the Literature.

Authors:  Claudia A Liegl; Michael A McGrath
Journal:  Int J Angiol       Date:  2015-02-09

Review 5.  Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment.

Authors:  Yuqing Gong; Sanjana Haque; Pallabita Chowdhury; Theodore J Cory; Sunitha Kodidela; Murali M Yallapu; John M Norwood; Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-04-20       Impact factor: 4.481

Review 6.  [Epidemiology and therapy of pain and depression during HIV and AIDS].

Authors:  I W Husstedt; D Reichelt; F Kästner; S Evers; K Hahn
Journal:  Schmerz       Date:  2009-12       Impact factor: 1.107

Review 7.  Cabergoline: a review of its use in the inhibition of lactation for women living with HIV.

Authors:  Karen J Tulloch; Philippe Dodin; Fannie Tremblay-Racine; Chelsea Elwood; Deborah Money; Isabelle Boucoiran
Journal:  J Int AIDS Soc       Date:  2019-06       Impact factor: 5.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.